bullish

Imugene Ltd

Imugene (IMU AU) Placement: Extended Runway for Clinical Programs Pipeline at Modest Equity Dilution

Imugene is raising A$80M via institutional placement to extend clinical pipeline runway. The placement participants are two leading investors with significant healthcare and biotechnology expertise.

Equity Capital Markets
241 Views, 18 Sep 2022 18:40
SUMMARY
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
  • Unlimited Research Summaries
  • Personalised Alerts
  • Custom Watchlists
  • Company Data & News
  • Events & Webinars
or
Trusted by:
Bloomberg
Societe Generale
SGX
Sequoia
Interactive Broker
Refinitiv
Already have an account? Sign In Now

Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Health CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Imugene (IMU AU) Placement: Extended Runway for Clinical Programs Pipeline at Modest Equity Dilution
    18 Sep 2022
  • Imugene (IMU AU): Clinical Trial Continued to Advance; Cash Position Still Strong
    26 Aug 2022
  • Imugene (IMU AU): Promising Pipeline And Financial Muscle Power Are Biggest Strengths
    24 May 2022
  • Imugene (IMU AU): Research Partnerships and Fund-Raising Entail Conviction on Solid Tumors Pipeline
    11 Feb 2022
x